I was just yesterday informed that Phase III Trial of AMX0035 is expected to start within a month in Europe (not certain, but expected).
I was asked by my doctor would I consider participating. However, I don't know what would be the best decision --> if I choose to participate I can't start with TUDCA now and there's a chance of getting a placebo during the trial. So a full year without any meaningful therapy. Alternatively, I could ignore the trial and just take TUDCA on my own, perhaps with ibudilast (ketas) if I can obtain it. I'm in an early stage of ALS. Does anyone have a suggestion what to do?
As for the 2nd component of AMX0035 (SPB), although it is available in NL I can't get a prescription from my doctor for it (as it is not proven for ALS). So without prescription is both unavailable and too expensive for me.